The aim of this work was to prepare new mucoadhesive nasal decongestant nanoparticles obtained by direct crosslinking between the cationic polymer chitosan and the anionic drug cromolyn. Different chitosan/cromolyn molar ratios were used in order to obtain nanoparticles of suitable size, encapsulation efficiency/drug loading and mucoadhesion. Moreover, the ability of the nanoparticles to deliver cromolyn into and through the nasal mucosa was evaluated. The obtained positively charged nanoparticles, sized 180-400 nm, showed interesting properties in terms of yield, mucoadhesion, encapsulation efficiency and drug loading. Release and permeation/penetration data indicated the ability of the nanoparticles to retain a high amount of cromolyn inside the mucosa, which is rich in mast cells. These findings suggest developing decongestant nanoparticles for potential treatment of allergic rhinitis.

Cromolyn-crosslinked chitosan nanoparticles for the treatment of allergic rhinitis / Angela Abruzzo, Teresa Cerchiara, Federica Bigucci, Giampaolo Zuccheri, Cristina Cavallari, Bruno Saladini, Barbara Luppi. - In: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. - ISSN 0928-0987. - ELETTRONICO. - 131:(2019), pp. 136-145. [10.1016/j.ejps.2019.02.015]

Cromolyn-crosslinked chitosan nanoparticles for the treatment of allergic rhinitis

Angela Abruzzo;Teresa Cerchiara;Federica Bigucci;Giampaolo Zuccheri;Cristina Cavallari;Barbara Luppi
2019

Abstract

The aim of this work was to prepare new mucoadhesive nasal decongestant nanoparticles obtained by direct crosslinking between the cationic polymer chitosan and the anionic drug cromolyn. Different chitosan/cromolyn molar ratios were used in order to obtain nanoparticles of suitable size, encapsulation efficiency/drug loading and mucoadhesion. Moreover, the ability of the nanoparticles to deliver cromolyn into and through the nasal mucosa was evaluated. The obtained positively charged nanoparticles, sized 180-400 nm, showed interesting properties in terms of yield, mucoadhesion, encapsulation efficiency and drug loading. Release and permeation/penetration data indicated the ability of the nanoparticles to retain a high amount of cromolyn inside the mucosa, which is rich in mast cells. These findings suggest developing decongestant nanoparticles for potential treatment of allergic rhinitis.
2019
Cromolyn-crosslinked chitosan nanoparticles for the treatment of allergic rhinitis / Angela Abruzzo, Teresa Cerchiara, Federica Bigucci, Giampaolo Zuccheri, Cristina Cavallari, Bruno Saladini, Barbara Luppi. - In: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES. - ISSN 0928-0987. - ELETTRONICO. - 131:(2019), pp. 136-145. [10.1016/j.ejps.2019.02.015]
Angela Abruzzo, Teresa Cerchiara, Federica Bigucci, Giampaolo Zuccheri, Cristina Cavallari, Bruno Saladini, Barbara Luppi
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/707259
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 21
social impact